Related News

7 things you should never reveal to others, according to psychology

Some things in life are best kept private to protect your peace, relationships, and personal growth. Oversharing can sometimes lead to unnecessary judgment, jealousy, or interference. It’s also wise to

7 (practical) weight loss transformation tips from those who have dropped the kilos (and kept it off)

One of the most important tips for effective weight loss is to eat more protein, especially if you are exercising. Protein helps keep you full longer, reduces hunger, and supports

10 pet dog breeds perfect for first-time owners

Are you planning to get a pet dog for yourself or your family? Here we list some dog breeds that are known for their friendly nature, easy-going temperament, and low-maintenance

5 ways a heart attack differs from a gas attack (and how to recognize them)

Heart Attack: Along with chest pain, a heart attack may cause shortness of breath, cold sweat, dizziness or lightheadedness, nausea, vomiting, and palpitations (irregular heartbeat). These symptoms indicate an urgent

Zydus Lifesciences receives 6 observations from USFDA for Gujarat API unit

Word Count: 490 | Estimated Reading Time: 3 minutes

Zydus Lifesciences on Saturday said it received six observations from the US Food and Drug Administration (USFDA) following a surveillance inspection of its active pharmaceutical ingredient (API) manufacturing facility in Dabhasa, Gujarat.
In a regulatory filing, the company stated that the inspection was conducted between April 21 and April 25, 2025.
“We wish to inform that the USFDA conducted a surveillance inspection at the group’s API Unit, located at Dabhasa in Gujarat. The inspection was conducted from April 21st to 25th, 2025. The inspection concluded with 6 observations and none of them were related to Data Integrity, ” Zydus Lifesciences said in a regulatory filing to NSE.
The company added that it is confident of addressing the observations in a timely manner.
On Friday, shares of Zydus Lifesciences ended lower on the National Stock Exchange. The stock declined by 2.45% to close at Rs 859.65, down Rs 21.55 from its previous close of Rs 880.25. It opened at Rs 879.65 and moved between an intraday high of Rs 882.35 and a low of Rs 858.00.

Source link